- Tiri
- http://47.105.50.196/karinaluisini
-
Results from the TRAVERSE trial were submitted in 2023, concluding that there was no increase in the risk of adverse cardiovascular outcomes in men using testosterone for hypogonadism.
- Joined on
2026-04-03
Block a user
No matching results found.